ZOU Lin
Researcher
E-mail: [email protected]
Tel: 021-52973107
Research interests：1. Research on new targets for diagnosis and treatment of childhood malignant tumors
2.Research on new strategies of birth defect prevention and control
Biography
Zou Lin, female, researcher, doctoral supervisor. She is also a member of the American Society of Hematology (ASH) and the World Society for New Screening (ISNS), a consultant for birth defects prevention and control, a consultant for prevention and control, and an expert for the development of technical specifications and training of personnel in the Department of Maternal and Child Health of the National Health Commission, a member of the Newborn Disease Screening Unit of the Clinical Laboratory Center of the National Health Commission, and a member of the inter-rater quality assessment committee of the Chinese Academy of Health Sciences. He is also a member of the Inter-quality Assessment Committee of the National Health Care Commission, the Newborn Screening Group of the Birth Defects Committee of the Chinese Society of Preventive Medicine, the Molecular Diagnostics Group and the Clinical Genetics Group of the Chinese Physicians Association, the Biomedical Research Committee of the Chinese Physicians Association, the Clinical Research Committee of the Shanghai Hospital Management Association, and other academic positions, and is a member of 18 high-level journals such as Cancer Res, Theranostics, and Cancer Lett. He is a reviewer for 18 high level journals including Cancer Res, Theranostics, Cancer Lett, etc. He has led 22 research projects (7 by NSFC), including the NSFC Major Research Program Incubation Project and the Key R&D Program of the Ministry of Science and Technology. He has led the development of 7 expert consensus on newborn screening technologies in China, edited 1 monograph, led 2 multicenter clinical studies on newborn screening and 3 clinical studies on stem cells in China, received 5 national invention patents, and made 12 presentations at international academic conferences. He has published 62 SCI papers as first/corresponding author in Cell Res, Neuro Oncol, Clin Cancer Res, Cancer Res, etc. He has been awarded the second prize of Sichuan Provincial Science and Technology Progress, the third prize of Chinese Medical Science and Technology Achievement, the first prize of Science and Technology Progress/Young Scholar Award of China Birth Defects Intervention Relief Foundation, and the Top Ten Young Scientist Award of Chongqing.
